Avid Bioservices price target raised to $11 from $6 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Avid Bioservices to $11 saying the company’s business development continues to ramp. The analyst reiterates a Buy rating on the shares following the Q1 results.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.